Review



dpp particle size  (Malvern Panalytical)


Bioz Verified Symbol Malvern Panalytical is a verified supplier
Bioz Manufacturer Symbol Malvern Panalytical manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Malvern Panalytical dpp particle size
    SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser <t>diffraction</t> data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.
    Dpp Particle Size, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 99/100, based on 58972 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/Mastersizer+3000%2B/pmc13750010-210-0-10
    Average 99 stars, based on 58972 article reviews
    dpp particle size - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "Spray‐Dried mRNA‐LNP Powder Enabling Multi‐Route Delivery With 3‐Year Refrigerated Stability"

    Article Title: Spray‐Dried mRNA‐LNP Powder Enabling Multi‐Route Delivery With 3‐Year Refrigerated Stability

    Journal: Advanced Science

    doi: 10.1002/advs.78751

    SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser diffraction data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.
    Figure Legend Snippet: SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser diffraction data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.

    Techniques Used: Analysis, Morphology, Concentration Assay, Labeling, Control

    Related Articles

    Zeta Potential Analyzer:

    Article Title: Red single wavelength emitting up-conversion nanoparticles modulate cellular dynamics and gene expression in T24 bladder cancer cells
    Article Snippet: .. The zeta potential of the UCNPs suspension was measured at 25 °C with the Malvern Zetasizer Nano-ZS 90 (USA), a zeta potential analyzer and particle sizing instrument. ..

    Article Title: Self-healing hydrogel loaded with M2pep-modified recombinant apoferritin enhanced chemotherapy in hepatocellular carcinoma via reprogramming tumor-associated macrophage
    Article Snippet: .. Encapsulation efficiency = weight of PTX in NPs weight of PTX × 100 % Drug loading = weight of PTX in NPs weight of PTX and albumin in NPs × 100 % The particle size and Zeta potential of BSA@PTX NPs were investigated by a particle and zeta potential analyzer (Malvern, U.K.). .. Encapsulation efficiency = weight of PTX in NPs weight of PTX × 100 % Drug loading = weight of PTX in NPs weight of PTX and albumin in NPs × 100 % The particle size and Zeta potential of BSA@PTX NPs were investigated by a particle and zeta potential analyzer (Malvern, U.K.).

    Article Title: Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation.
    Article Snippet: The mapping images were acquired form a transmission electron microscope (JEM 2100 F, JEOL). .. The zeta potential and hydrodynamic size were measured by a particle and molecular charge analyzer (Zetasizer Nano ZS, Malvern). .. FTIR spectra were recorded by a Fourier transform infrared spectrometer (Thermo Nicolet IS 50, Thermo Fisher).

    Article Title: Cholesterol modulates the interaction of sodium salt with negatively charged phospholipid membrane.
    Article Snippet: We present a systematic study on how alkali metal salts, like NaCl and NaI, affect negatively charged phospholipid vesicles using a range of experimental methods.. Our goal was to find out how chain saturation and cholesterol affect the interaction between the ions and the membrane.. An isothermal titration calorimetry study on large unilamellar vesicles made from dimyristoyl phosphatidylcholine (DMPC) revealed that Na shows higher binding affinity to the gel phase at 15 C compared to the fluid phase at 30 C. Further, cations also show stronger affinity to the membrane in the fluid composed of saturated lipids than that of unsaturated lipids.

    Suspension:

    Article Title: Red single wavelength emitting up-conversion nanoparticles modulate cellular dynamics and gene expression in T24 bladder cancer cells
    Article Snippet: .. The zeta potential of the UCNPs suspension was measured at 25 °C with the Malvern Zetasizer Nano-ZS 90 (USA), a zeta potential analyzer and particle sizing instrument. ..

    Encapsulation:

    Article Title: Self-healing hydrogel loaded with M2pep-modified recombinant apoferritin enhanced chemotherapy in hepatocellular carcinoma via reprogramming tumor-associated macrophage
    Article Snippet: .. Encapsulation efficiency = weight of PTX in NPs weight of PTX × 100 % Drug loading = weight of PTX in NPs weight of PTX and albumin in NPs × 100 % The particle size and Zeta potential of BSA@PTX NPs were investigated by a particle and zeta potential analyzer (Malvern, U.K.). .. Encapsulation efficiency = weight of PTX in NPs weight of PTX × 100 % Drug loading = weight of PTX in NPs weight of PTX and albumin in NPs × 100 % The particle size and Zeta potential of BSA@PTX NPs were investigated by a particle and zeta potential analyzer (Malvern, U.K.).

    other:

    Article Title: Diatomaceous earth composition with a low endotoxin content
    Article Snippet: Herein, the average particle size of the calcined diatomaceous earth particles is measured by laser diffraction (accuracy: ±1%), using a conventional particle sizing instrument (Mastersizer 2000, Malvern Instruments).

    Article Title: Oscillating microbubble array-based metamaterials (OMAMs) for rapid isolation of high-purity exosomes.
    Article Snippet: The size distribution of exosomes was measured via dynamic light scattering using a particle and molecular size analyzer (Zetasizer Nano ZS, Malvern Instruments, UK).



    Similar Products

    94
    Cytiva Europe hydrophobic carboxylate beads
    Hydrophobic Carboxylate Beads, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/Sera-Mag+Speedbead+carboxylate-modified+%5BE3%5D+magnetic+particles/pmc13759077-149-10-13
    Average 94 stars, based on 1 article reviews
    hydrophobic carboxylate beads - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    OriGene tspo lentiviral particles
    Tspo Lentiviral Particles, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/PBR+(TSPO)+Rabbit+Polyclonal+Antibody/10__1038_slash_s41467___026___79500___x-587-4-15
    Average 90 stars, based on 1 article reviews
    tspo lentiviral particles - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    97
    MathWorks Inc particle swarm
    Particle Swarm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/Global+Optimization+Toolbox/pm42669385-270-11-13
    Average 97 stars, based on 1 article reviews
    particle swarm - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology camkiiγ
    Camkiiγ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/CaMKII%CE%B4+shRNA+(h2)+Lentiviral+Particles/pm42962661-976-18-28
    Average 94 stars, based on 1 article reviews
    camkiiγ - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mef2a
    Mef2a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/MEF-2A+shRNA+(h)+Lentiviral+Particles/pm42962661-976-20-28
    Average 93 stars, based on 1 article reviews
    mef2a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology shrna lentiviral particles targeting trpv4
    Shrna Lentiviral Particles Targeting Trpv4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/TRPV4+shRNA+(h)+Lentiviral+Particles/pm42962661-976-10-28
    Average 94 stars, based on 1 article reviews
    shrna lentiviral particles targeting trpv4 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology mef2d
    Mef2d, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/MEF-2D+shRNA+(h)+Lentiviral+Particles/pm42962661-976-23-28
    Average 94 stars, based on 1 article reviews
    mef2d - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology shrna lentiviral particle transduction scrambled shrna lentiviral particles
    Shrna Lentiviral Particle Transduction Scrambled Shrna Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/Control+shRNA+Lentiviral+Particles-A/pm42962661-976-0-28
    Average 96 stars, based on 1 article reviews
    shrna lentiviral particle transduction scrambled shrna lentiviral particles - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology human tcf3
    xx
    Human Tcf3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/E2A+shRNA+(h2)+Lentiviral+Particles/pmc13754957-93-5-10
    Average 94 stars, based on 1 article reviews
    human tcf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    Malvern Panalytical dpp particle size
    SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser <t>diffraction</t> data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.
    Dpp Particle Size, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/particle/Mastersizer+3000%2B/pmc13750010-210-0-10
    Average 99 stars, based on 1 article reviews
    dpp particle size - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    xx

    Journal: Apoptosis

    Article Title: Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma

    doi: 10.1007/s10495-026-02477-x

    Figure Lengend Snippet: xx

    Article Snippet: Short hairpin RNA (shRNA) targeting human TCF3 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA; Cat No. sc-63307-V).

    Techniques:

    xx

    Journal: Apoptosis

    Article Title: Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma

    doi: 10.1007/s10495-026-02477-x

    Figure Lengend Snippet: xx

    Article Snippet: Short hairpin RNA (shRNA) targeting human TCF3 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA; Cat No. sc-63307-V).

    Techniques:

    Carrimycin binds TCF3 to exert cytotoxic effects in BL cells. A Bioinformatic identification of candidate upstream transcription factors regulating shared DEGs in Carrimycin-treated cells using the ChEA3 platform integrated with ReMap ChIP-seq datasets. The red box highlights TCF3. B Computational molecular docking of ISP I into the active site of TCF3 (Binding Energy = − 5.9 kcal/mol). C – E 100 ns molecular dynamics (MD) simulation validating the stability of the TCF3-ISP I complex, showing C root mean square deviation (RMSD) trajectories, D intermolecular hydrogen bond frequencies, and (E) the Free Energy Landscape (FEL). F Cellular Thermal Shift Assay (CETSA) in Raji cells treated with DMSO or Carrimycin across a 62–86 °C temperature gradient. Line graph quantification (right) demonstrates thermal stabilization of TCF3 by Carrimycin. G Cycloheximide (CHX, 100 µg/mL) chase assay in Raji cells co-treated with DMSO or Carrimycin for 0 to 8 h. (H) Western blot analysis of TCF3 protein expression in Raji and NAMALWA cells treated with increasing concentrations of Carrimycin (0, 5, 10, 20 µM) for 24 h. I Western blot validation of stable shRNA-mediated knockdown of TCF3 in NAMALWA cells. J CCK-8 cell viability curves of NAMALWA-shCtrl and NAMALWA-shTCF3 cells treated with graded concentrations of Carrimycin (0–10 µM) for 24 h

    Journal: Apoptosis

    Article Title: Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma

    doi: 10.1007/s10495-026-02477-x

    Figure Lengend Snippet: Carrimycin binds TCF3 to exert cytotoxic effects in BL cells. A Bioinformatic identification of candidate upstream transcription factors regulating shared DEGs in Carrimycin-treated cells using the ChEA3 platform integrated with ReMap ChIP-seq datasets. The red box highlights TCF3. B Computational molecular docking of ISP I into the active site of TCF3 (Binding Energy = − 5.9 kcal/mol). C – E 100 ns molecular dynamics (MD) simulation validating the stability of the TCF3-ISP I complex, showing C root mean square deviation (RMSD) trajectories, D intermolecular hydrogen bond frequencies, and (E) the Free Energy Landscape (FEL). F Cellular Thermal Shift Assay (CETSA) in Raji cells treated with DMSO or Carrimycin across a 62–86 °C temperature gradient. Line graph quantification (right) demonstrates thermal stabilization of TCF3 by Carrimycin. G Cycloheximide (CHX, 100 µg/mL) chase assay in Raji cells co-treated with DMSO or Carrimycin for 0 to 8 h. (H) Western blot analysis of TCF3 protein expression in Raji and NAMALWA cells treated with increasing concentrations of Carrimycin (0, 5, 10, 20 µM) for 24 h. I Western blot validation of stable shRNA-mediated knockdown of TCF3 in NAMALWA cells. J CCK-8 cell viability curves of NAMALWA-shCtrl and NAMALWA-shTCF3 cells treated with graded concentrations of Carrimycin (0–10 µM) for 24 h

    Article Snippet: Short hairpin RNA (shRNA) targeting human TCF3 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA; Cat No. sc-63307-V).

    Techniques: ChIP-sequencing, Docking Assay, Binding Assay, Molecular Dynamics Simulation, Stability, Thermal Shift Assay, Western Blot, Analysis, Expressing, Biomarker Discovery, shRNA, Knockdown, CCK-8 Assay

    Schematic illustration of the proposed therapeutic mechanism of Carrimycin in Burkitt lymphoma. Carrimycin suppresses Burkitt lymphoma through a dual mechanism of action. It promotes a reduction in TCF3 protein abundance and is associated with decreased TCF3 stability, inhibiting tonic B-cell receptor (BCR) signaling and its downstream PI3K-AKT survival axis. Simultaneously, Carrimycin triggers accumulation of reactive oxygen species (ROS), inducing DNA damage marked by elevated γ-H2AX levels. This convergence of BCR signal termination and oxidative stress drives G0/G1 cell cycle arrest and caspase-dependent apoptosis, thereby potentially halting tumor growth

    Journal: Apoptosis

    Article Title: Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma

    doi: 10.1007/s10495-026-02477-x

    Figure Lengend Snippet: Schematic illustration of the proposed therapeutic mechanism of Carrimycin in Burkitt lymphoma. Carrimycin suppresses Burkitt lymphoma through a dual mechanism of action. It promotes a reduction in TCF3 protein abundance and is associated with decreased TCF3 stability, inhibiting tonic B-cell receptor (BCR) signaling and its downstream PI3K-AKT survival axis. Simultaneously, Carrimycin triggers accumulation of reactive oxygen species (ROS), inducing DNA damage marked by elevated γ-H2AX levels. This convergence of BCR signal termination and oxidative stress drives G0/G1 cell cycle arrest and caspase-dependent apoptosis, thereby potentially halting tumor growth

    Article Snippet: Short hairpin RNA (shRNA) targeting human TCF3 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA; Cat No. sc-63307-V).

    Techniques: Quantitative Proteomics, Stability

    Carrimycin suppresses BL growth in subcutaneous and intracranial xenograft models. A Experimental schematic for the subcutaneous Raji xenograft model in NSG mice treated with Carrimycin (55 mg/kg via intraperitoneal injections) or vehicle control. (B-D) Quantification of tumor size B , C and final tumor weight D from subcutaneous xenografts showing growth suppression by Carrimycin. E Representative Hematoxylin and Eosin (H&E) and immunohistochemical (IHC) staining of subcutaneous tumor tissues for proliferation (Ki-67), BCR signaling (p-SYK), and TCF3. F Experimental design for the intracranial tumor model established via injection of luciferase-expressing Raji cells. G Representative bioluminescence images monitoring intracranial tumor growth in mice from the vehicle and treatment groups. H Quantification of tumor bioluminescence intensity at 7, 11, 14, 18, and 21 days post-implantation. (I) Individual tumor growth trajectories for each mouse bearing intracranial xenografts in the vehicle control (Left) and Carrimycin-treated (Right) groups. (J) Kaplan–Meier survival curve demonstrating extended median overall survival (mOS) in the Carrimycin-treated intracranial cohort (27 days vs 20 days). * P < 0.05, **** P < 0.0001

    Journal: Apoptosis

    Article Title: Carrimycin suppresses the TCF3-BCR signaling axis and induces oxidative DNA damage in Burkitt lymphoma

    doi: 10.1007/s10495-026-02477-x

    Figure Lengend Snippet: Carrimycin suppresses BL growth in subcutaneous and intracranial xenograft models. A Experimental schematic for the subcutaneous Raji xenograft model in NSG mice treated with Carrimycin (55 mg/kg via intraperitoneal injections) or vehicle control. (B-D) Quantification of tumor size B , C and final tumor weight D from subcutaneous xenografts showing growth suppression by Carrimycin. E Representative Hematoxylin and Eosin (H&E) and immunohistochemical (IHC) staining of subcutaneous tumor tissues for proliferation (Ki-67), BCR signaling (p-SYK), and TCF3. F Experimental design for the intracranial tumor model established via injection of luciferase-expressing Raji cells. G Representative bioluminescence images monitoring intracranial tumor growth in mice from the vehicle and treatment groups. H Quantification of tumor bioluminescence intensity at 7, 11, 14, 18, and 21 days post-implantation. (I) Individual tumor growth trajectories for each mouse bearing intracranial xenografts in the vehicle control (Left) and Carrimycin-treated (Right) groups. (J) Kaplan–Meier survival curve demonstrating extended median overall survival (mOS) in the Carrimycin-treated intracranial cohort (27 days vs 20 days). * P < 0.05, **** P < 0.0001

    Article Snippet: Short hairpin RNA (shRNA) targeting human TCF3 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA; Cat No. sc-63307-V).

    Techniques: Xenograft Assay, Control, Immunohistochemical staining, Immunohistochemistry, Injection, Luciferase, Expressing

    SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser diffraction data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.

    Journal: Advanced Science

    Article Title: Spray‐Dried mRNA‐LNP Powder Enabling Multi‐Route Delivery With 3‐Year Refrigerated Stability

    doi: 10.1002/advs.78751

    Figure Lengend Snippet: SEM analysis of mRNA‐LNP DPP morphology and matrix integrity. SEM images of mRNA‐LNP DPPs formulated at 5% w/v post‐reconstitution sugar concentration with (a) mannitol, (b) sucrose, and (c) trehalose, showing spherical particles with smooth surfaces and sizes consistent with laser diffraction data. Ethanol treatment of rhodamine‐DOPE‐labeled DPPs at 5% w/v post‐reconstitution trehalose concentration: (d) untreated control, (e) after vigorous vortexing (preserved morphology), and (f) after overnight stirring (particle shrinkage and deformation), demonstrating mRNA‐LNP entrapment within the sugar matrix core rather than surface coating.

    Article Snippet: DPP particle size was measured by laser diffraction (Mastersizer 3000, Malvern Panalytical).

    Techniques: Analysis, Morphology, Concentration Assay, Labeling, Control